SK8242000A3 - Site-specific preparation of polyethylene glycol-grf conjugates - Google Patents
Site-specific preparation of polyethylene glycol-grf conjugates Download PDFInfo
- Publication number
- SK8242000A3 SK8242000A3 SK824-2000A SK8242000A SK8242000A3 SK 8242000 A3 SK8242000 A3 SK 8242000A3 SK 8242000 A SK8242000 A SK 8242000A SK 8242000 A3 SK8242000 A3 SK 8242000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- hgrf
- peg
- lys
- conjugates
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97121264A EP0922446A1 (de) | 1997-12-03 | 1997-12-03 | Lösungsphase Verfahrung zur ortspezifischer Herstellung von GRF-PEG Konjugaten |
| PCT/EP1998/007748 WO1999027897A1 (en) | 1997-12-03 | 1998-12-01 | Site-specific preparation of polyethylene glycol-grf conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK8242000A3 true SK8242000A3 (en) | 2001-01-18 |
Family
ID=8227732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK824-2000A SK8242000A3 (en) | 1997-12-03 | 1998-12-01 | Site-specific preparation of polyethylene glycol-grf conjugates |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US6528485B1 (de) |
| EP (2) | EP0922446A1 (de) |
| JP (2) | JP2001524505A (de) |
| KR (1) | KR100561768B1 (de) |
| CN (1) | CN1149967C (de) |
| AR (1) | AR017780A1 (de) |
| AT (1) | ATE236607T1 (de) |
| AU (1) | AU755285B2 (de) |
| BG (1) | BG64815B1 (de) |
| BR (1) | BR9815159A (de) |
| CA (1) | CA2312004C (de) |
| DE (1) | DE69813291T2 (de) |
| DK (1) | DK1037587T3 (de) |
| EA (1) | EA004269B1 (de) |
| EE (1) | EE200000319A (de) |
| ES (1) | ES2194376T3 (de) |
| HK (1) | HK1034203A1 (de) |
| HU (1) | HUP0100507A3 (de) |
| IL (2) | IL136551A0 (de) |
| NO (1) | NO327238B1 (de) |
| NZ (1) | NZ504570A (de) |
| PL (1) | PL192082B1 (de) |
| PT (1) | PT1037587E (de) |
| SI (1) | SI1037587T1 (de) |
| SK (1) | SK8242000A3 (de) |
| TR (1) | TR200001615T2 (de) |
| TW (1) | TWI254641B (de) |
| UA (1) | UA73716C2 (de) |
| WO (1) | WO1999027897A1 (de) |
| ZA (1) | ZA9811068B (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
| US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| JP2004510751A (ja) * | 2000-10-05 | 2004-04-08 | アレス トレーディング ソシエテ アノニム | 位置選択的液相ペグ化 |
| EP1234583A1 (de) | 2001-02-23 | 2002-08-28 | F. Hoffmann-La Roche Ag | PEG-Konjugate des HGF-NK4 |
| US20030171285A1 (en) * | 2001-11-20 | 2003-09-11 | Finn Rory F. | Chemically-modified human growth hormone conjugates |
| ES2291613T3 (es) | 2002-01-16 | 2008-03-01 | Biocompatibles Uk Limited | Conjugados de polimeros. |
| US7998705B2 (en) * | 2002-08-06 | 2011-08-16 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc | Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol |
| JP2006504694A (ja) * | 2002-09-18 | 2006-02-09 | サントル・オスピタリエ・ドゥ・リュニヴェルシテ・ドゥ・モントリオール・（シー・エイチ・ユー・エム） | Ｇｈｒｈ類似体 |
| GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| AU2003206158A1 (en) * | 2003-01-18 | 2004-08-13 | Pegsphere Co., Ltd. | Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated peg peptides using the same |
| WO2005010163A2 (en) * | 2003-07-15 | 2005-02-03 | Barros Research Institute | Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv) |
| AU2004259727A1 (en) * | 2003-07-15 | 2005-02-03 | Barros Research Institute | Compositions and methods for immunotherapy of cancer and infectious diseases. |
| JP2008504216A (ja) * | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | モノクローナル抗体の生成のための方法および組成物 |
| CA2554755A1 (en) * | 2004-01-28 | 2005-08-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
| CN100355784C (zh) * | 2004-02-12 | 2007-12-19 | 江苏恒瑞医药股份有限公司 | 聚乙二醇修饰α－干扰素1b的制备方法 |
| US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US6986264B1 (en) * | 2004-07-15 | 2006-01-17 | Carrier Corporation | Economized dehumidification system |
| PL1824988T3 (pl) | 2004-11-12 | 2018-01-31 | Bayer Healthcare Llc | Ukierunkowana na miejsce modyfikacja czynnika VIII |
| WO2007016105A2 (en) * | 2005-07-26 | 2007-02-08 | Rhodia Inc. | Polymers with pendant poly(alkyleneoxy) substituent groups and their use in personal care applications |
| US20070238656A1 (en) * | 2006-04-10 | 2007-10-11 | Eastman Kodak Company | Functionalized poly(ethylene glycol) |
| WO2007130453A2 (en) | 2006-05-02 | 2007-11-15 | Allozyne, Inc. | Non-natural amino acid substituted polypeptides |
| US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| PT2054074E (pt) * | 2006-08-04 | 2014-11-07 | Prolong Pharmaceuticals Llc | Eritropoietina modificada |
| US20080083154A1 (en) * | 2006-10-05 | 2008-04-10 | Timothy M Gregory | Bait retention fish hook |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
| US20090104114A1 (en) * | 2007-09-21 | 2009-04-23 | Cytimmune Sciences, Inc. | Nanotherapeutic Colloidal Metal Compositions and Methods |
| CA2706700A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
| WO2010053990A2 (en) * | 2008-11-04 | 2010-05-14 | Janssen Pharmaceutica Nv | Crhr2 peptide agonists and uses thereof |
| CA2755395C (en) | 2009-03-20 | 2015-02-24 | Hanmi Holdings Co., Ltd. | Method for preparing a site-specific physiologically active polypeptide conjugate |
| EP2421548A4 (de) * | 2009-04-20 | 2012-09-26 | Theratechnologies Inc | Verwendung von (hexenoyl-trans-3)hgrf(l-44)nh2 und simvastatin in einer kombinationstherapie |
| EP2421547A1 (de) * | 2009-04-20 | 2012-02-29 | Theratechnologies Inc. | Verwendung von (hexenoyl-trans-3)hgrf(1-44)nh2 und ritonavir in einer kombinationstherapie |
| WO2011005540A1 (en) | 2009-06-22 | 2011-01-13 | Burnham Institute For Medical Research | Methods and compositions using peptides and proteins with c-terminal elements |
| AU2010315131A1 (en) | 2009-11-04 | 2012-05-31 | Janssen Pharmaceutica Nv | Method for treating heart failure with stresscopin-like peptides |
| WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
| BR112013027150A2 (pt) | 2011-04-21 | 2017-06-06 | Theratechnologies Inc | thera |
| EP2715291A4 (de) | 2011-05-31 | 2015-10-21 | Airware Inc | Rekalibrierung von ab-ndir-gassensoren |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US10064940B2 (en) | 2013-12-11 | 2018-09-04 | Siva Therapeutics Inc. | Multifunctional radiation delivery apparatus and method |
| CA2986927C (en) | 2015-05-28 | 2023-12-19 | Institut National De La Recherche Scientifique | Inhibitors of prototypic galectin dimerization and uses thereof |
| DK3445778T3 (da) * | 2016-04-19 | 2020-10-12 | Griffon Pharmaceuticals Int Sa | Pegylerede bioaktive peptider og anvendelser deraf |
| CN110317826B (zh) * | 2019-05-22 | 2020-11-10 | 中国农业大学 | 调控PvGRF9含量或活性的物质在调控植物茎生长发育中的应用 |
| WO2021133407A1 (en) | 2019-12-27 | 2021-07-01 | Compagnie Generale Des Etablissements Michelin | Rubber mix with high specific surface area and high structure acetylene carbon black |
| CA3206260A1 (en) | 2021-01-28 | 2022-08-04 | Ilse Roodink | Anti-sars-cov-2 spike glycoprotein antibodies and the therapeutic use thereof |
| WO2024081918A1 (en) | 2022-10-14 | 2024-04-18 | Talem Therapeutics Llc | Anti-trkb/cd3 antibodies and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4563352A (en) * | 1982-10-04 | 1986-01-07 | The Salk Institute For Biological Studies | Human pancreatic GRF |
| DE69026306T2 (de) * | 1989-05-27 | 1996-10-17 | Sumitomo Pharma | Verfahren für die Herstellung von Polyethylenglykolderivate und modifizierte Proteine. |
| CA2085362A1 (en) * | 1990-06-29 | 1991-12-30 | Arthur M. Felix | Histidine substituted growth hormone releasing factor analogs |
| JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| EP0542937A1 (de) * | 1991-04-09 | 1993-05-26 | F. Hoffmann-La Roche Ag | Analoge von wachstumshormonfreisetzenden faktoren (grf) |
| EP0518295A3 (en) * | 1991-06-14 | 1993-09-01 | Millipore Corporation | Allyl side chain protection in peptide synthesis |
| FR2687681B1 (fr) * | 1992-02-20 | 1995-10-13 | Transgene Sa | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses. |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| AU7273196A (en) * | 1995-11-03 | 1997-05-29 | Theratechnologies Inc. | Method of grf peptides synthesis |
-
1997
- 1997-12-03 EP EP97121264A patent/EP0922446A1/de not_active Withdrawn
-
1998
- 1998-01-12 UA UA2000063885A patent/UA73716C2/uk unknown
- 1998-12-01 HU HU0100507A patent/HUP0100507A3/hu unknown
- 1998-12-01 TR TR2000/01615T patent/TR200001615T2/xx unknown
- 1998-12-01 EP EP98959898A patent/EP1037587B1/de not_active Expired - Lifetime
- 1998-12-01 SI SI9830400T patent/SI1037587T1/xx unknown
- 1998-12-01 DK DK98959898T patent/DK1037587T3/da active
- 1998-12-01 SK SK824-2000A patent/SK8242000A3/sk unknown
- 1998-12-01 PT PT98959898T patent/PT1037587E/pt unknown
- 1998-12-01 AT AT98959898T patent/ATE236607T1/de active
- 1998-12-01 CA CA002312004A patent/CA2312004C/en not_active Expired - Lifetime
- 1998-12-01 NZ NZ504570A patent/NZ504570A/en unknown
- 1998-12-01 BR BR9815159-2A patent/BR9815159A/pt not_active Application Discontinuation
- 1998-12-01 KR KR1020007005736A patent/KR100561768B1/ko not_active IP Right Cessation
- 1998-12-01 CN CNB988117592A patent/CN1149967C/zh not_active Expired - Fee Related
- 1998-12-01 PL PL341139A patent/PL192082B1/pl not_active IP Right Cessation
- 1998-12-01 JP JP2000522885A patent/JP2001524505A/ja active Pending
- 1998-12-01 ES ES98959898T patent/ES2194376T3/es not_active Expired - Lifetime
- 1998-12-01 AU AU15633/99A patent/AU755285B2/en not_active Expired
- 1998-12-01 EE EEP200000319A patent/EE200000319A/xx unknown
- 1998-12-01 IL IL13655198A patent/IL136551A0/xx unknown
- 1998-12-01 EA EA200000601A patent/EA004269B1/ru not_active IP Right Cessation
- 1998-12-01 DE DE69813291T patent/DE69813291T2/de not_active Expired - Lifetime
- 1998-12-01 WO PCT/EP1998/007748 patent/WO1999027897A1/en active IP Right Grant
- 1998-12-02 AR ARP980106098A patent/AR017780A1/es active IP Right Grant
- 1998-12-03 ZA ZA9811068A patent/ZA9811068B/xx unknown
-
1999
- 1999-01-26 TW TW088101139A patent/TWI254641B/zh not_active IP Right Cessation
-
2000
- 2000-05-24 NO NO20002664A patent/NO327238B1/no not_active IP Right Cessation
- 2000-05-29 BG BG10448A patent/BG64815B1/bg unknown
- 2000-06-04 IL IL136551A patent/IL136551A/en not_active IP Right Cessation
- 2000-06-05 US US09/587,460 patent/US6528485B1/en not_active Expired - Lifetime
-
2001
- 2001-07-16 HK HK01104960A patent/HK1034203A1/xx not_active IP Right Cessation
-
2002
- 2002-11-20 US US10/299,790 patent/US6869932B2/en not_active Expired - Lifetime
-
2004
- 2004-12-15 US US11/011,617 patent/US7317002B2/en not_active Expired - Fee Related
-
2009
- 2009-10-30 JP JP2009251100A patent/JP5431874B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK8242000A3 (en) | Site-specific preparation of polyethylene glycol-grf conjugates | |
| AU770712B2 (en) | Methods for glucagon suppression | |
| US20060063699A1 (en) | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | |
| US20080085860A1 (en) | Selective Vpac2 Receptor Peptide Agonists | |
| US7256258B2 (en) | Regioselective liquid phase pegylation | |
| US20090118167A1 (en) | Selective Vpac2 Receptor Peptide Agonists | |
| AU2001295589A1 (en) | Regioselective liquid phase pegylation | |
| US20100048460A1 (en) | Selective vpac2 receptor peptide agonists | |
| US20090082276A1 (en) | Selective vpac2 receptor peptide agonists | |
| CN113710692A (zh) | 长效glp-2类似物 | |
| US7332473B2 (en) | Peptides and medicinal compositions containing the same | |
| CZ20002055A3 (cs) | Způsob selektivní přípravy specifických konjugátů polyethylenglykol - GRF | |
| MXPA00005138A (en) | Site-specific preparation of polyethylene glycol-grf conjugates |